Matches 1 - 50 out of 141 1 2 3 >


Match Document Document Title
US20140072617 METHOD FOR PREVENTING OR SLOWING DOWN THE APPEARANCE OF THE EFFECTS OF SKIN AGEING USING A TOCOPHERYL PHOSPHATE IN LIPOSOMES  
The invention relates to a method for preventing or slowing down the appearance of the effects of skin ageing, in particular for slowing down the formation of wrinkles on the face, and reducing or...
US20100305070 TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS  
The disclosure relates to novel compounds for use in the treatment or prophylaxis of cancers and other proliferative conditions that are for example characterized by cells that express cytochrome...
US20140135281 METHODS FOR CONTROLLING VARROA MITES  
The present invention relates to methods and compositions comprising cyromazine for the control of bee mites and for the reduction of bee mite infestations, such as the control and reduction of...
US20150011512 TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS  
The invention relates to novel compounds for use in the treatment or prophylaxis of cancers and other proliferative conditions that are for example characterized by cells that express cytochrome...
US20120190639 TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS  
The invention relates to novel compounds for use in the treatment or prophylaxis of cancers and other proliferative conditions that are for example characterized by cells that express cytochrome...
US20140248375 Combination Therapy for Treating Proliferative Diseases  
The present invention relates generally to new chemical combinations and methods for their use in the treatment of proliferative diseases and in particular cancer.
US20110130367 Combination Therapy for Treating Proliferative Diseases  
The present invention relates generally to new chemical combinations and methods for their use in the treatment of proliferative diseases and in particular cancer.
US20110082098 NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE  
Novobiocin analogues are useful in methods of treating, inhibiting, and/or preventing cyst formation in autosomal dominant polycystic kidney disease (ADPKD) in a subject. The disclosure provides...
US20110294732 ERYTHROPOLETIN COMPLEMENTATION OR REPLACEMENT  
The present invention provides methods and compositions to replace up to 90% of erythropoietin use in the treatment of anemias and hypoxias. The method employs acid and salt forms of...
US20150218121 PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME  
Described herein are Δ9-THC prodrugs, methods of making Δ9-THC prodrugs, formulations comprising Δ9-THC prodrugs and methods of using Δ9-THC. One embodiment described herein relates to the...
US20120289484 PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME  
Described herein are Δ9-THC prodrugs, methods of making Δ9-THC prodrugs, formulations comprising Δ9-THC prodrugs and methods of using Δ9-THC. One embodiment described herein relates to the...
US20120232038 CRYSTALLINE FORMS OF (3R, 3AS, 6AR) - HEXAHYDROFURO [2,3-B] FURAN-3-YL (1S,2R) - (1-{4-[ (DIETHOXYPHOSPHORYL) METHOXY] PHENY1}-3-HYDROXY-4- [4-METHOXY-N- (2-METHYLPROPYL) BENZENESUL - FONAMIDO] BUTAN-2-YL) CARBAMATE  
The present inventions provides crystalline forms of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-(1-{4-[(diethoxyphosphoryl)methoxy]phenyl}-3-hydroxy -4-[4-methoxy-N-(2-methylpropyl)benzene...
US20150087620 AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES  
The present invention provides a compound represented by the following formula (I): wherein each symbol is as described in the DESCRIPTION, which has a superior peripheral blood lymphocyte...
US20120034216 SPIROKETALS  
The present invention relates to spiroketal compounds that are useful in methods of treating or preventing protozoal infections, parasitic infections, bacterial infections, cell proliferative...
US20110244022 TRANSDERMAL DELIVERY PATCH  
A composition suitable for use in a transdermal delivery patch for administration of an opioid, the composition comprising a phosphate compound of tocopherol and a polymer carrier.
US20120282327 PHOSPHATE-CONTAINING NANOPARTICLE DELIVERY VEHICLE  
A phosphate-containing nanoparticle delivery vehicle includes nanoparticle, an active ingredient, and a phosphodiester moiety connecting the nanoparticle and the active ingredient and forms a...
US20140255509 COMPOSITION  
Compositions and formulations comprising a non-neutralised tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder...
US20150224124 REDUCING THE REPRODUCTIVE CAPACITY OF MAMMALS  
Provided are compositions and methods for reducing the reproductive capacity of mammals. The compositions and methods involve the use and administration of (a) a diterpenoid epoxide comprising a...
US20130302389 COSMETIC COMPOSITION CONTAINING AT LEAST TWO OSMOLYTES WITH A MOISTURIZING OR ANTIAGING EFFECT  
The present invention relates to a cosmetic composition, which comprises a combination of at least two osmolytes chosen from the group comprising taurine or a derivative thereof, inositol, betaine...
US20050025737 Compositions containing melon extracts  
Cosmetic compositions composed of melon fruit extract in combination with magnesium ascorbyl phosphate (MAP). These compositions may be preventative as well as reparative in treating wrinkles and...
US20110117155 PESTICIDE STRIPS FOR CONTROL OF MITES IN HONEYBEES  
Pesticide strips used to control parasitic mites in honeybees. The pesticide strips are designed to have a lifetime or period of existence, after which the strip no longer exists in its original...
US20140100194 COLD MENTHOL RECEPTOR-1 ANTAGONISTS  
The invention is directed to TRPM8 antagonists of Formula (I). More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions,...
US20130137755 SYSTEM FOR DELIVERING THERAPEUTIC AGENTS INTO LIVING CELLS AND CELLS NUCLEI  
The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of...
US20110053847 METHODS OF TREATING VASODILATORY SHOCK  
The invention encompasses methods of decreasing the lumenal diameter of a blood vessel by contacting the vessel with a myosin light chain phosphatase inhibitor.
US20060121094 Preparation comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals  
The present invention provides a preparation comprising 1,3 and/or 1,6 beta glucans, for use in the treatment or prevention of infection, inflammation, and/or traumatic conditions. The preparation...
US20060058267 Pharmaceutical compositions comprising a NOS inhibitor  
This invention relates to methods of treating neurodegenerative diseases and inhibiting neurological damage, comprising administering to a patient in need of such treatment an N-NOS inhibitor in...
US20150218193 Water-Soluble Derivatives and Prodrugs of Acacetin and Methods of Making and Using Thereof  
Water-soluble derivatives and/or prodrugs of acacetin are described herein. The compounds can be used as cardioprotection agents against myocardial infarction induced by ischemia-reperfusion. In...
US20090104258 Use of tocopheryl phosphate as an agent for preventing or slowing down the appearance of the effects of skin ageing  
The invention relates to a cosmetic composition of a tocopheryl phosphate, especially in its dl or d form, or in the form of a cosmetically acceptable salt or ester thereof, as a cosmetic agent...
US20130274212 Sesterterpene Compounds and Use Thereof  
The present invention relates to sesterterpene compounds, to the precursors thereof that are hydrolysable in a living body, or to the pharmaceutically acceptable salts thereof, and also relates to...
US20080118579 Medical Device and Its use  
The invention relates to a medical device comprising non-sintered bioactive glass particles or fibres having a diameter in the range 5-100 μm, bioactive glass comprising SiO2, Na2O, CaO, K2O, MgO,...
US20110124603 Trioxane Dimer Sulfur Compounds  
The disclosure provides novel trioxane sulfur dimers having Formula I: methods for their preparation, pharmaceutical compositions containing these compounds, and methods for treating cancer,...
US20070078111 LPA2 receptor agonist inhibitors of CFTR  
Methods and compositions for treating or preventing diarrhea are disclosed. The methods comprise administering to an individual a therapeutically effective amount of an LPA2 receptor agonist for...
US20080026074 Method of short term skin wrinkles correction using strontium divalent ion  
A method for the treatment of skin damage using strontium divalent ion in a dermatologically acceptable carrier is provided, usually an essential oil distillate. The compositions are applied...
US20100204183 Substituted Phosphonates and Their Use In Decreasing Amyloid Aggregates  
The invention relates to novel and known substituted phosphonates for use in ameliorating amyloid aggregates, particularly for use in the treatment of Alzheimer's disease.
US20110110886 SMALL MOLECULE INHIBITORS OF AUTOTAXIN AND METHODS OF USE  
Autotaxin (ATX) is a prometastatic enzyme initially isolated from the conditioned media of human melanoma cells that stimulates a myriad of biological activities including angiogenesis and the...
US20100004208 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS  
The present invention relates generally to substituted benzofurans, benzothiophenes, and indoles and their use as tubulin polymerisation inhibitors.
US20110003774 COMPOUNDS HAVING ANTI-PROLIFERATIVE PROPERTIES  
There is provided a method of inhibiting the occurrence of one of more of the following conditions:—the proliferation of monocytes/macrophages; or—the proliferation of smooth muscle cells; or—the...
US20090186856 MICRONUTRIENT PHOSPHATES AS DIETARY AND HEALTH SUPPLEMENTS  
There is provided a dietary or health supplement comprising an effective amount of a micronutrient selected from the group consisting of phosphate derivatives of tocopherol, ubiquinol, ascorbic...
US20150133401 COMBINATION THERAPY INVOLVING A VASCULAR DISRUPTING AGENT AND AN AGENT WHICH TARGETS HYPOXIA  
The present invention provides a method for treating a proliferative disease in a patient. The method comprises administering to a patient in need thereof: a) a vascular disrupting agent and (b)...
US20100173014 METHODS OF MAKING AND USING NANO SCALE PARTICLES  
The instant invention discloses methods of preparing phospholipid delivery systems encapsulating one or more bio-affecting compounds, said methods comprising solubilizing a heterogeneous...
US20110105437 Mitochondrially Delivered Anti-Cancer Compounds  
This invention relates to anti-cancer compounds and to methods for treating or preventing cancer. In one aspect the invention concerns mitochondrially delivered pro-oxidant anti-cancer compounds...
US20050232891 Methods of treating skin with diphosphonate derivatives  
The present invention provides for the administration of aryl-substituted 1,1-diphosphonate compounds to increase the dermal collagen content of skin and effect improvement in photoaged skin,...
US20120214769 Novel Antagonists of the Glucagon Receptor  
The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity....
US20060189579 Method of stabilizing ascorbyl phosphate and salts thereof  
Ascorbyl phosphate is stabilized against degradation by phosphatases by coating with a lipid.
US20090203649 DERMATOLOGICAL ANTI-WRINKLE AGENT  
A dermatological anti-wrinkle agent and an anti-wrinkle cosmetic are stable and satisfactorily effective against wrinkles. The dermatological anti-wrinkle agent comprises a tocopherol phosphate...
US20150140088 SPIROSTEROID SYSTEMS ACTING AS NEUROPROTECTIVE AND ANTI-INFLAMMATORY AGENTS  
The present invention relates to the fields of chemistry and pharmacy and, in particular, to the production of novel molecular entities: esterane derivatives fused with spirostanes rings, acting...
US20090005348 Compounds Having Cytokine Modulating Properties  
A method of modulating one or more immuno-regulatory cytokines, such as pro-inflammatory and/or anti-inflammatory cytokines, comprising administering to a subject a therapeutically effective...
US20120252763 NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS  
The present invention relates to the use of a novel class of cancer stem cell pathway (CSCP) inhibitors; to methods of using such compounds to treat refractory, recurrent, or metastatic cancers;...
US20080139512 Method for minimizing or avoiding adverse effects of vesicants  
The invention pertains to compositions and methods to treat the adverse effects of mustard chemicals and other toxic compounds, such as chemical warfare agents, exposure to which normally induces...
US20090082313 Multikinase Inhibitors for Use in the Treatment of Cancer  
The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I): wherein...

Matches 1 - 50 out of 141 1 2 3 >